Piramal Pharma invests $90M in Lexington to double sterile injectables output by 2027, boosting ADC capacity and creating jobs in U.S. pharma manufacturing.
Fangzhou Inc. at PHARMCHINA Showcases AI-Powered Healthcare
The 4th Annual Internet + Pharma Conference showcased AI-powered healthcare innovations by Fangzhou Inc., aligning with China\'s digital transformation goals.
Infudopa SubC Parkinsons Therapy offers a wearable, patient-friendly treatment for advanced PD, co-developed by Neuraxpharm and Dizlin for better care.
PDUFA Crucial for Biopharmaceutical Innovation in the US
As the US cements its position in the development of innovative drugs, acts such as PDUFA are indeed necessary for a consistent biopharmaceutical innovation.
Merck to Acquire Verona for $10B, COPD Drug in Focus
There is yet another development as Merck acquires Verona and with it a potential blockbuster drug Ohtuvayre when it comes to the treatment of COPD for $10B.
